Bios Capital Management, LP Portfolio Holdings
Bios Capital Management, LP
- $72.6 Billion
- Q2 2025
Bios Capital Management, LP has filed its 13F form on August 12, 2025 for Q2 2025 where it was disclosed a total value porftolio of $72.6 Billion distributed in 9 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Actuate Therapeutics Inc with a value of $60.9B, Ocuphire Pharma, Inc. with a value of $3.46B, Lantern Pharma Inc. with a value of $3.4B, Rein Therapeutics Inc with a value of $2.37B, and Cognition Therapeutics Inc with a value of $1.86B.
Examining the 13F form we can see an decrease of $6.6B in the current position value, from $79.2B to 72.6B.
Bios Capital Management, LP is based out at Fort Worth, TX
Below you can find more details about Bios Capital Management, LP portfolio as well as his latest detailed transactions.